Figure 3.
Use of antihyperglycemic classes by CKD stage and prior CVD.
Note. CKD = chronic kidney disease; CVD = cardiovascular disease; DPP-4 = dipeptidyl peptidase-4; SGLT2 = sodium glucose co-transporter 2; GLP-1 = glucagon-like peptide 1; CAD = coronary artery disease; PAD = peripheral artery disease; TIA = transient ischemic attack.